Qian Li Selected Research

ErbB Receptors (EGF Receptor)

3/2024	Tucidinostat Plus Exemestane as a Neoadjuvant in Early-Stage, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
7/2022	A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis.
3/2022	[Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients  Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis:  A Single-center Retrospective Study].
9/2019	Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer.
3/2019	[A Single Center, Retrospective Analysis of Prognosis in Non-small Cell Lung Cancer Patients with Peritoneal Carcinomatosis].
5/2018	Predicting epidermal growth factor receptor gene amplification status in glioblastoma multiforme by quantitative enhancement and necrosis features deriving from conventional magnetic resonance imaging.
1/2018	Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys.
1/2017	Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma.
1/2017	[Quantitative analysis of enhanced MRI features for predicting epidermal growth factor receptor gene amplification in glioblastoma multiforme with radiomic method].
10/2016	NF-κB-dependent transcriptional upregulation of cyclin D1 exerts cytoprotection against hypoxic injury upon EGFR activation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qian Li Research Topics

Disease

506	Neoplasms (Cancer) 12/2024 - 05/2004
146	Inflammation (Inflammations) 05/2024 - 09/2004
93	Neoplasm Metastasis (Metastasis) 04/2024 - 07/2004
90	Infections 06/2024 - 09/2003
82	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2009
61	Carcinogenesis 06/2024 - 08/2007
60	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 04/2009
56	Hypoxia (Hypoxemia) 05/2024 - 02/2006
55	Type 2 Diabetes Mellitus (MODY) 04/2024 - 07/2009
54	Fibrosis (Cirrhosis) 12/2024 - 01/2004
54	Pain (Aches) 02/2024 - 11/2003
52	Stomach Neoplasms (Stomach Cancer) 04/2024 - 12/2008
46	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 08/2007
36	Insulin Resistance 01/2023 - 05/2010
34	Ischemia 03/2024 - 07/2006
33	COVID-19 04/2024 - 01/2020
32	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 11/2011
32	Hypertension (High Blood Pressure) 04/2024 - 03/2012
31	Neuroinflammatory Diseases 03/2024 - 08/2014
29	Sepsis (Septicemia) 03/2024 - 07/2010
29	Lung Neoplasms (Lung Cancer) 03/2024 - 11/2011
27	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 09/2004
27	Body Weight (Weight, Body) 02/2024 - 01/2007
27	Obesity 07/2023 - 02/2011
27	Reperfusion Injury 03/2023 - 07/2006
27	Carcinoma (Carcinomatosis) 01/2023 - 01/2010
26	Stroke (Strokes) 05/2024 - 05/2009
26	Wounds and Injuries (Trauma) 04/2024 - 01/2013
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2013
24	Colonic Neoplasms (Colon Cancer) 01/2024 - 08/2007
24	Atherosclerosis 01/2024 - 04/2007
24	Hyperglycemia 01/2024 - 08/2004
23	Multiple Myeloma 04/2024 - 02/2010
23	Lung Injury 01/2024 - 05/2012
22	Necrosis 05/2024 - 03/2008
21	Cognitive Dysfunction 02/2024 - 09/2004
21	Melanoma (Melanoma, Malignant) 06/2023 - 01/2016
20	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2023 - 09/2015
19	Ischemic Stroke 05/2024 - 08/2010
19	Myocardial Infarction 11/2023 - 07/2011
19	Asthma (Bronchial Asthma) 05/2023 - 01/2009
19	Adenocarcinoma 11/2022 - 09/2012
18	Hypersensitivity (Allergy) 02/2024 - 04/2005
18	Nasopharyngeal Carcinoma 12/2023 - 01/2016
18	Colitis 12/2023 - 12/2009
17	Non-alcoholic Fatty Liver Disease 04/2024 - 01/2015
17	Acute Lung Injury 02/2024 - 10/2007
16	Hemorrhage 12/2023 - 01/2014
16	Diabetes Mellitus 11/2023 - 05/2006
16	Heart Failure 09/2023 - 08/2007
16	Ovarian Neoplasms (Ovarian Cancer) 05/2023 - 09/2015
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2024 - 01/2010
15	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2024 - 01/2007

Drug/Important Bio-Agent (IBA)

209	Proteins (Proteins, Gene)FDA Link 07/2024 - 09/2004
125	Biomarkers (Surrogate Marker)IBA 12/2024 - 04/2009
76	MicroRNAs (MicroRNA)IBA 03/2024 - 12/2011
71	CytokinesIBA 03/2024 - 08/2010
67	Long Noncoding RNAIBA 01/2024 - 07/2015
57	Messenger RNA (mRNA)IBA 01/2024 - 09/2008
54	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2007
54	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 08/2004
45	RNA (Ribonucleic Acid)IBA 04/2024 - 04/2006
43	LipidsIBA 04/2024 - 11/2007
38	Insulin (Novolin)FDA Link 11/2023 - 07/2009
37	Interleukin-6 (Interleukin 6)IBA 12/2024 - 10/2007
35	EnzymesIBA 05/2024 - 05/2010
34	Peptides (Polypeptides)IBA 12/2023 - 09/2005
32	VaccinesIBA 06/2024 - 02/2005
30	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 09/2010
30	Circular RNAIBA 03/2024 - 01/2018
29	AntioxidantsIBA 05/2024 - 05/2012
29	Therapeutic UsesIBA 01/2024 - 08/2008
26	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024 - 11/2009
26	LipopolysaccharidesIBA 06/2023 - 08/2007
25	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 04/2015
24	Small Interfering RNA (siRNA)IBA 01/2024 - 08/2008
23	HydrogelsIBA 11/2023 - 05/2018
23	CholesterolIBA 10/2023 - 06/2005
22	CateninsIBA 03/2024 - 08/2011
22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023 - 10/2007
21	AntibodiesIBA 01/2024 - 10/2008
20	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2019
19	CollagenIBA 01/2024 - 01/2007
19	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2012
18	AntigensIBA 01/2024 - 02/2005
18	Oxygen (Dioxygen)IBA 01/2024 - 02/2006
17	LigandsIBA 01/2024 - 01/2012
17	Streptozocin (Streptozotocin)FDA Link 01/2024 - 05/2006
17	Indicators and Reagents (Reagents)IBA 01/2024 - 06/2010
17	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2013
16	AcidsIBA 05/2024 - 07/2004
16	Transcription Factors (Transcription Factor)IBA 05/2024 - 10/2012
16	InflammasomesIBA 03/2024 - 12/2015
16	InterferonsIBA 12/2023 - 01/2015
15	Analgesics (Analgesic Drugs)IBA 02/2024 - 06/2012

Therapy/Procedure

219	Therapeutics 05/2024 - 02/2004
85	Drug Therapy (Chemotherapy) 03/2024 - 01/2009
36	Immunotherapy 06/2024 - 09/2019
23	Radiotherapy 03/2024 - 01/2016
16	Photochemotherapy (Photodynamic Therapy) 05/2024 - 07/2011